Cargando…
Acquisition of cancer stem cell properties in osteosarcoma cells by defined factors
BACKGROUND: Cancer stem cells (CSCs) are considered to be responsible for tumor initiation, formation, and poor prognosis of cancer patients. However, the rarity of CSCs in clinical samples makes it difficult to elucidate characteristics of CSCs, especially in osteosarcoma (OS). The aim of this stud...
Autores principales: | Fujiwara, Shuichi, Kawamoto, Teruya, Kawakami, Yohei, Koterazawa, Yasufumi, Hara, Hitomi, Takemori, Toshiyuki, Kitayama, Kazumichi, Yahiro, Shunsuke, Kakutani, Kenichiro, Matsumoto, Tomoyuki, Matsushita, Takehiko, Niikura, Takahiro, Koyanagi-Aoi, Michiyo, Aoi, Takashi, Kuroda, Ryosuke, Akisue, Toshihiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7532109/ https://www.ncbi.nlm.nih.gov/pubmed/33008481 http://dx.doi.org/10.1186/s13287-020-01944-9 |
Ejemplares similares
-
Regulatory roles of miRNAs 16, 133a, and 223 on osteoclastic bone destruction caused by breast cancer metastasis
por: Kitayama, Kazumichi, et al.
Publicado: (2021) -
Identification and characterization of slow-cycling cells in Ewing sarcoma
por: Yahiro, Shunsuke, et al.
Publicado: (2022) -
Clinical Outcomes and Prognostic Factors in Soft Tissue Sarcoma Patients After Unplanned Excision
por: Takemori, Toshiyuki, et al.
Publicado: (2022) -
Surgical outcomes of metastatic bone tumors in the extremities (Surgical outcomes of bone metastases)
por: Hara, Hitomi, et al.
Publicado: (2021) -
Gemcitabine and docetaxel combination chemotherapy for advanced bone and soft tissue sarcomas: protocol for an open-label, non-randomised, Phase 2 study
por: Hara, Hitomi, et al.
Publicado: (2019)